Clinical Trials in Oncology & Rare Disease Europe
26-27 November, 2025 // Munich, Germany
Join Worldwide Clinical Trials at Clinical Trials in Oncology & Rare Disease Europe.
19
days leftAbout event
Join pharma and biotech leaders as they collaborate to tackle industry challenges through innovation and strategic partnerships. If you’re attending Clinical Trials in Oncology & Rare Disease Europe, stop by booth #35 to connect with our team.
On November 26, Matt Cooper, PhD, Executive Director, Therapeutic Strategy Lead, Oncology, and Nathan Chadwick, Senior Director, Therapeutic Strategy Lead, Rare Disease, will present “CAR-T Crossroads: Oncology Insights Driving Rare Disease Innovation” at 12:15 PM EST.
Their session will explore emerging CAR-T trial trends in Oncology and discuss how regulatory, design, logistical, and operational lessons learned can be applied to advance the next generation of CAR-T trials in rare diseases.
Date
Wednesday to Thursday
26 – 27 November, 2025
Venue
Munich Marriott Hotel City West
Landsberger Str. 156, 80687 München, Germany
Matt Cooper, PhD
Executive Director, Therapeutic Strategy Lead, Oncology
Matt Cooper is the Executive Director, Therapeutic Strategy Lead, Oncology and has 25 years of experience in the life science industry conducting clinical trials across all phases. His experience spans roles at sponsors, sites, and the NHS, and he has extensive experience in site management and expanded use of oncology therapies. He is passionate about building effective relationships between industry stakeholders to drive innovation and patient access.
